Unibar Corp. launched Maitake Pt78, a clinically validated immune modulating mushroom extract.
Unibar Corp. (Houston, TX) launched Maitake Pt78, a clinically validated immune modulating mushroom extract. Maitake mushrooms are rich in minerals, vitamins, amino acids, and beta-glucan. To support the immune system, the beta-glucans bind to macrophages, either activating or inhibiting the release of key cytokines. The ingredient’s ability to source the glucan-protein complex creates a source of immune-boosting monosaccharides. The extract uses a proprietary manufacturing process that ensures potency and purity. It delivers a dosage as 15 mg/d.
“Right now, consumers want products that will provide them with better control over their health and improving their immune health is definitely top-of-mind this year. The clinical studies on maitake mushrooms have shown that it provides significant support to the immune system by helping to activate T cells and influencing a proper cytokine response,” said Sevanti Mehta, president of Unibar, in a press release. “Maitake Pt78 is an affordable and high-quality ingredient that is designed to help the body better support healthy immune function by balancing the inflammatory response, promoting healthy cellular function and enhancing the body’s immune defenses. These three benefits deliver a much-needed balance to the immune response, meeting current demand for functional ingredients that will make a difference during today’s health challenges.”
Maitake Pt78 is suitable for a wide variety of product applications and formats, including multivitamins, immune support, travel, stress and sports performance formulas for all ages. It is manufactured according to ISO, cGMP, HAACP, and PMDA requirements and is GRAS.